A research peptide certificate of analysis (CoA) is the practitioner’s primary verification document for product identity, purity, and analytical quality. Most practitioners glance at the purity percentage and move on. That’s a mistake. A CoA contains 8-12 distinct data fields, each of which carries specific information about how the peptide was tested, what was found, and what the data does and does not prove. Practitioners who learn to read a CoA field-by-field can identify supplier quality issues, analytical method weaknesses, and labeling inconsistencies before they become operational problems.
This guide walks through every field on a credible research peptide CoA, explains what the data means, and flags the patterns that distinguish a real analytical document from a marketing document dressed up as analytical work. It builds on the framework in the research peptide category practitioner reference and assumes the reader has access to CoAs from current or candidate suppliers.
What a CoA is and what it is not
A certificate of analysis is a document produced by an analytical lab (either the manufacturer’s internal lab or a contract testing lab) that reports the results of specific tests performed on a specific batch of finished product. A CoA is batch-specific by definition — it documents what was tested on one batch, not what is generally true of the product line.
A CoA is not a regulatory document. It is not approved by the FDA, does not certify potential wellness benefit, and does not establish the product’s suitability for any particular application. USP General Chapter <1225> on validation of compendial procedures establishes the analytical performance characteristics that should be demonstrated in any method used to generate CoA data, but the CoA itself is a report of test results, not a regulatory endorsement.
The CoA header fields
[ypb-catalog-download]
Product name and identifier
The product name should match the labeled product exactly. Variations in nomenclature (peptide name, abbreviation, CAS number, sequence) are acceptable as long as they unambiguously identify the same compound. CoAs that list only an abbreviation without sequence verification are weaker than CoAs that include sequence confirmation.
Batch number or lot number
Every CoA should reference a specific batch number that matches the batch number on the product label. If the CoA lacks a batch number, or the batch number does not match the product received, the CoA is functionally a marketing document, not an analytical record. This is one of the most common quality red flags in low-tier supplier documentation.
Date of manufacture and date of analysis
Manufacturing date and analysis date should be within a reasonable window of each other (typically less than 30 days). Long gaps between manufacture and analysis can indicate inventory aging issues or analytical backlog. Both dates should precede the practitioner’s order date.
Analyst name and signature
Credible analytical labs name the responsible analyst on the CoA, with either a digital or wet signature. Anonymous CoAs (no named analyst) are weaker than signed CoAs because they remove the chain of accountability that quality systems are built around.
Purity and identity fields
Purity by HPLC
This is the headline field most practitioners focus on. The purity percentage represents the proportion of the main peak area relative to total peak area in a reverse-phase HPLC chromatogram. Research peptides typically run at 95-99% purity by HPLC, with 98%+ representing the standard quality bar for practitioner-grade product.
The number itself is less informative than the method used to generate it. A credible CoA specifies the HPLC method: column type (typically C18), mobile phase composition (typically water/acetonitrile gradient with 0.1% TFA), detection wavelength (typically 214 nm or 220 nm), flow rate, and run time. Without these method details, the purity percentage cannot be independently evaluated. USP General Chapter <621> on chromatography establishes the system suitability parameters that should be reported.
Mass spectrometry confirmation
Mass spectrometry (typically ESI-MS or MALDI-MS) confirms the molecular weight of the peptide, which is the most reliable identity check available. The CoA should list both the theoretical molecular weight (calculated from the peptide sequence) and the observed molecular weight (from MS analysis), with the two values matching within typical instrument accuracy (±0.1 to ±1.0 Daltons depending on instrument type).
A CoA without MS data has no rigorous identity confirmation. HPLC purity alone proves that one compound is dominant in the sample, not that the dominant compound is the labeled peptide. ICH Q2(R2) guidelines on validation of analytical procedures explicitly require both specificity and identity confirmation for quantitative analytical methods.
Peptide content or mass balance
Peptide content (also called net peptide content or mass balance) reports the actual peptide mass as a percentage of total sample mass. This number differs from HPLC purity because total sample mass includes water, counterions (typically acetate or trifluoroacetate), and any salts. A peptide can be 99% pure by HPLC and 75-85% peptide by mass.
This field matters for accurate dosing in research applications. A research protocol that assumes 100% peptide content when the actual mass balance is 80% will systematically under-dose by 20%. Credible CoAs report mass balance explicitly. Suppliers that omit this field are forcing the practitioner to assume mass balance, which is a recipe for analytical drift.
Composition and contaminant fields
[ypb-related-reading url=”https://uat.yourpeptidebrand.com/?p=16016″ title=”Peptide Stability and Storage: Lyophilized vs Reconstituted” description=”Related practitioner reference covering the adjacent topic in this pillar.”]
Water content (Karl Fischer titration)
Lyophilized peptides retain residual water that affects mass balance calculations and storage stability. Karl Fischer titration is the standard method for water content measurement, typically reporting water as 2-8% by mass for lyophilized peptides. CoAs that omit water content are leaving a meaningful mass balance variable unmeasured.
Counterion content (acetate or TFA)
Synthetic peptides are typically isolated as acetate or trifluoroacetate (TFA) salts depending on synthesis chemistry. Counterion content is reported as percentage by mass and typically runs 5-15% for acetate salts and 8-20% for TFA salts. Counterion data affects mass balance interpretation and matters for research applications where counterion identity is relevant.
Residual solvents
Peptide synthesis uses organic solvents (DMF, DCM, acetonitrile, TFA) that can carry through to finished product as residuals. Comprehensive CoAs report residual solvent levels by gas chromatography (GC) against ICH Q3C limits. Many research-grade peptide CoAs omit this field because routine residual solvent testing adds cost without typically affecting research applications. Practitioners running protocols sensitive to solvent residuals should request this data explicitly.
Bacterial endotoxin or pyrogen testing
For research peptides used in cell culture or research applications where bacterial contamination matters, endotoxin testing (typically Limulus Amebocyte Lysate or LAL assay) reports endotoxin levels in EU/mg. Most research-grade peptides do not include endotoxin testing on standard CoAs but suppliers should be able to provide it on request for an additional cost. FDA’s bioanalytical method validation guidance establishes the analytical framework for endotoxin testing when conducted.
Reading the chromatogram
Many credible CoAs include the actual HPLC chromatogram as an attached image or PDF page. Practitioners who can read chromatograms have access to information that purity percentages alone obscure.
Key chromatogram features to evaluate:
- Main peak shape: Symmetrical, sharp peaks indicate clean separation. Tailing or fronting peaks can indicate column degradation, sample overload, or compound instability.
- Peak resolution: The main peak should be clearly separated from neighboring impurity peaks. Co-eluting impurities inflate apparent purity.
- Baseline behavior: The baseline should be flat and quiet between peaks. Drift, noise, or step changes indicate analytical issues that may affect quantification accuracy.
- Run time and retention time: The main peak should elute within the documented method’s run window. Peaks appearing outside the expected window may indicate identity issues.
Peer-reviewed analytical chemistry literature consistently emphasizes that chromatogram review by trained personnel is the single highest-information-density check available for HPLC-based purity assessment.
The five red flags that should fail a CoA
[ypb-related-reading url=”https://uat.yourpeptidebrand.com/?p=15820″ title=”Research Peptide Category Practitioner Reference” description=”The parent pillar guide covering the full topic in depth.”]
- No batch number matching the product label
- Purity claim without HPLC method details
- No mass spectrometry identity confirmation
- No mass balance or peptide content data
- No named analyst or analytical lab attribution
A CoA with any one of these gaps is documentation theater rather than analytical record-keeping. A CoA with two or more is a hard fail for any practitioner with operational discipline. The supplier vetting framework covered in the RUO compliance playbook includes CoA quality as a primary supplier evaluation criterion.
How to use CoAs operationally
Three operational habits convert CoA review from documentation review into quality management:
File CoAs systematically. Save every CoA received with the corresponding batch number, supplier, and receipt date. When quality issues surface downstream, batch-level CoA history is the diagnostic starting point.
Spot-check independent lab verification. For 5-10% of incoming batches, send a sample to an independent ISO 17025-accredited lab for confirmatory HPLC and MS analysis. Compare independent results to supplier CoA. Persistent discrepancies indicate supplier quality system weakness.
Share CoAs with end customers on request. Practitioner customers increasingly request CoAs as part of their own quality due diligence. A brand that can provide batch-specific CoAs on request signals operational maturity that competitors providing only generic documentation cannot match.
Frequently asked questions
How long should I keep CoAs on file?
At minimum, keep CoAs for the entire shelf life of the corresponding product plus one year. Practitioners with formal quality systems typically retain CoAs for 5-7 years to support traceability and complaint investigation.
Should I request CoAs for every order, or just the first one?
Every order. CoAs are batch-specific, and batches change with every production run. Suppliers operating credible quality systems generate a new CoA for every batch and can provide it on request without additional cost.
What’s the difference between a CoA and a Certificate of Compliance (CoC)?
A Certificate of Compliance is a statement that the product meets specifications, typically without detailed analytical data. A Certificate of Analysis includes the actual test results. CoAs are stronger documentation than CoCs. Suppliers offering only CoCs are providing weaker quality evidence.
Can suppliers fabricate CoAs?
Yes, and it happens in the research peptide industry. The defense is independent verification (spot-check confirmatory analysis at an external lab) and supplier-level due diligence. CoAs from suppliers without ISO 17025-accredited analytical labs or named analysts are higher-risk for fabrication.
Are research peptide CoAs ever audited by regulators?
CoAs themselves are not subject to FDA approval, but FDA inspections of registered establishments can include review of quality records including CoAs. For practitioners reselling research peptides, the operational risk from CoA fabrication is supply chain disruption and reputational damage rather than direct regulatory action.
[ypb-spoke-cta headline=”Build your research peptide brand the right way.” body=”YourPeptideBrand is the white-label supplier 250+ practitioner brands trust for RUO-compliant peptides, dropship fulfillment, and CoA-backed sourcing.”]